Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)-Reference-Cited by-同舟云学术

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

Published:2020-07 Issue: Volume:151 Page:102978
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Rolfo Christian,Cardona Andrés F.,Cristofanilli Massimo,Paz-Ares Luis,Diaz Mochon Juan Jose,Duran Ignacio^ORCID,Raez Luis E.,Russo Alessandro^ORCID,Lorente Jose A.,Malapelle Umberto,Gil-Bazo Ignacio,Jantus-Lewintre Eloisa,Pauwels Patrick,Mok Tony,Serrano María José

Funder

Lung Cancer Research Foundation-Pfizer

Guardant Health and Biomark inc

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference117 articles.

1. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution;Abbosh;Nature,2017

2. Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection;Abbosh;Nat. Rev. Clin. Oncol.,2018

3. Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer;Aggarwal;JAMA Oncol.,2019

4. Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression;Aldea;J. Thorac. Oncol.,2020

5. Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer;Anagnostou;Cancer Res.,2019

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies;The Journal of Liquid Biopsy;2024-06

2. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications;British Journal of Cancer;2024-03-26

3. Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions;Biomedicines;2024-03-07

4. Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer;Annals of Oncology;2024-02

5. Analysis of the safety and effectiveness of endoscopic nasal dacryocystorhinostomy in the remedy of chronic dacryocystitis;Medicine;2024-01-19